Creative Biolabs announced the launch of its OncoVirapy™ platform, which offers a highly competitive one-stop service for ...
Researchers use cryo-EM and optical tweezers to investigate how an antiviral interacts with the herpes simplex virus.
AZoLifeSciences on MSN
Giant virus with a massive genome and unusual infection strategy
Ushikuvirus, a newly identified giant virus, showcases unique cytopathic effects and structural features, enhancing knowledge ...
5 Department of Developmental and Regenerative biology, iORGANtech Limited Company, Jiangsu, China Background Hepatitis E virus (HEV), the leading global cause of acute viral hepatitis, lacks robust ...
The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is ...
Vesicle trafficking mechanisms play indispensable roles throughout the viral replication cycle, though their stage-specific regulatory mechanisms during infection require further elucidation. Notably, ...
The global pandemic may be over, but SARS-CoV-2 continues to infect people around the world. Indeed, the United States has recorded roughly 750 deaths from COVID-19 over the past month. Now, an siRNA ...
The FDA granted priority review, with a decision expected by June 19, 2025. LEN represents a novel class of HIV therapies by targeting the viral capsid, a multifunctional protein essential for HIV ...
On February 18, 2025, Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir (LEN), a groundbreaking twice-yearly injectable HIV-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results